Navigation Links
Decoy makes sitting duck of superbugs
Date:12/4/2007

Scientists from the John Innes Centre have proven that by taking a short stretch of DNA from a bacterium and delivering it with an existing antibiotic they can switch off antibiotic resistance.

Together with technology transfer company PBL, the scientists have launched a spin-out company, Procarta Biosystems Ltd, to develop the technology.

The DNA sequence acts as a decoy, disrupting gene expression and blocking resistance, said Dr Michael McArthur from JIC.

We are putting genetic information directly into drugs. This is the first application of a DNA based therapy.

The scientists have also patented a way of discovering decoys in bacteria without necessarily having to know the genes involved. This means they can develop effective new drugs against any bacterium within a couple of years and at a fraction of the normal cost.

The technology can give fresh patent life to existing antibiotics - when combined with a decoy they can be patented as a new drug.

This comes at a time when the number of new antibiotics receiving approval has dramatically declined. Faced with antibiotic resistance the pharmaceutical industry is unlikely to be able to deliver new products.

Natural resistance will always be hot on the heels of a new antibiotic because they co-evolve, said Dr McArthur. Ours is not a traditional pharmaceutical approach and provides a completely new challenge to bacteria.

The technology can also be used to improve the production of antibiotics by bacteria and to produce enzymes and other compounds using bacteria for use in industrial processes.

Many industrial processes are harsh and unsustainable, using petrochemicals, high temperatures and creating toxic by-products. In industrial biotechnology, also called white biotechnology, bacteria make medically and commercially important compounds biologically.

By using bacteria, many industrial processes could be cleaned up, said Dr McArthur.

The Procarta scientists found that the bacterium Streptomyces produces a particularly high yield of enzymes and proteins. Unusually, it can also secrete the proteins it produces so they do not have to be extracted.

Streptomyces is the enzyme producing bacterium with bells and whistles, set to make a major contribution to a market already predicted to be worth 400 million by 2010, said Dr McArthur.

We use the products of white biotechnology in our everyday lives. They contribute to ingredients in the food we eat, energy we use that has been generated with renewable biomass rather than fossil fuels, medicines we take, and everyday products such as detergents, paint and paper.


'/>"/>

Contact: Zoe Dunford
zoe.dunford@bbsrc.ac.uk
44-160-325-5111
Norwich BioScience Institutes
Source:Eurekalert

Related biology news :

1. New drug makes weight loss safer
2. How mother of thousands makes plantlets
3. For honey bee queens, multiple mating makes a difference
4. Scientists spy enzyme that makes us unique
5. Thinking makes it so: Science extends reach of prosthetic arms
6. Choosing dry or wet food for cats makes little difference
7. Technique controls nanoparticle size, makes large numbers
8. MU study finds that sitting may increase risk of disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2019)... ... 2019 , ... Advanced Clinical, a clinical research services organization, ... opening of new offices in Bucharest and Timisoara, Romania. Advanced Clinical’s increased interest ... in clinical trials. , Advanced Clinical’s entrance into Romania includes interdisciplinary teams ...
(Date:10/10/2019)... , ... October 10, 2019 , ... ... anesthesia and ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual ... takes place on October 19-21 in Orlando, Florida, and will provide more than ...
(Date:10/4/2019)... (PRWEB) , ... October 04, 2019 , ... ... 2019 will be held November 10 at the Grand Elysée Hamburg Rothenbaumchaussee in ... to Europe again this November,” said Miao Guo, Vice President of Operations and ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Murrieta Genomics , the ... and venture capital companies in Silicon Valley at a special Life Science showcase ... will be held at the JJ Lake Business Center located at 340 E. Middlefield ...
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., the ... that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now ... demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/30/2019)... Texas (PRWEB) , ... September 30, 2019 , ... ... the materials science newsletter from Rigaku Corporation , is now available online ... related to X-ray based materials science, including X-ray diffraction, fluorescence and imaging, and ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... Drug resistance ... by the World Health Organization, with MRSA becoming one of the most serious concerns. ... were 1,218 reported cases of community-associated MRSA (CA-MRSA), or a seven-fold of the figure ...
Breaking Biology Technology: